Pelargonium tablets

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

Pelargonium sidoides, Quantity: 30 mg (Equivalent: Pelargonium sidoides, Qty 150 mg)

Disponibbli minn:

Mega Lifesciences (Australia) Pty Ltd

INN (Isem Internazzjonali):

Pelargonium sidoides

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; crospovidone; colloidal anhydrous silica; magnesium stearate; Carnauba Wax; titanium dioxide; indigo carmine; sunset yellow FCF; purified talc; allura red AC; polyvinyl alcohol; macrogol 3350; lecithin

Rotta amministrattiva:

Oral

Indikazzjonijiet terapewtiċi:

Treatment of acute,uncomplicated upper respiratory tract infections including common cold, acute bronchitis and acute sinusitis.

Sommarju tal-prodott:

Visual Identification: Purple film coated round tablet; Container Type: Blister Pack; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2014-04-14